Issuance Of Minister's Decision No.264-2025 Regarding The Work Of Pharmaceutical Institutions On Med

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	494,147 L.L
B05BC01	MANNITOL 10% USP INJECTION	G	Mannitol - 10%	10%	Injectable solution	430,943 L.L
J01CR02	MOXICLAV FORTE	G	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	298,333 L.L
A01AB09	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	229,093 L.L
B05BC01	MANNITOL 10% USP INJECTION	G	Mannitol - 10%	10%	Injectable solution	326,367 L.L
A01AB09	MICOZOLE	G	Miconazole - 20mg/g	20mg/g	Gel	104,820 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L
L01EB02	MIRATA	G	Erlotinib (HCl) - 100mg	100mg	Tablet, film coated	77,379,009 L.L
M01AC56	MOBITIL	G	Meloxicam - 15mg, Beta-cyclodextrine - 75mg		Tablet, film coated	212,327 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Cream	335,321 L.L
J01CR02	MEGAMOX-JPI	G	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Suspension	435,405 L.L
N02AA01	MORPHINE (CHLORHYDRATE) RENAUDIN	G	Morphine HCl - 1mg/ml	1mg/ml	Injectable solution	626,231 L.L
J01CR02	MOXICLAV BIS	G	Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml	457mg/5ml	Powder for suspension	287,582 L.L
L01EB02	MIRATA	G	Erlotinib (HCl) - 150mg	150mg	Tablet, film coated	88,599,923 L.L
A06AG11	MINILAX	G	Sodium citrate (dihydrate) - 900mg/10ml, Sodium lauryl sulfate - 150mg/10ml, Glycerol - 1200mg/10ml, Sorbic acid - 10mg/10ml, Sorbitol - 9.96mg/10ml		Solution	474,824 L.L
N02AA01	MORPHINE MEDIS	G	Morphine HCl - 10mg/ml	10mg/ml	Injectable solution	1,050,885 L.L
N02AA01	MORPHILINE	G	Morphine sulfate - 10mg/5ml	10mg/5ml	Solution	189,418 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Lotion	239,332 L.L
J01CR02	MEGAMOX-JPI ES	G	Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml	600mg	Powder for suspension	507,972 L.L
R01AD09	METASONE	G	Mometasone furoate - 50mcg/actuation	50mcg/actuation	Spray	419,791 L.L
A02BB01	MISOFAR	G	Misoprostol - 200mcg	200mcg	Tablet	1,546,763 L.L
J01GB06	MIACIN	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	2,015,764 L.L
R01AD09	METASPRAY	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	349,399 L.L
A02BB01	MISOFAR	G	Misoprostol - 25mcg	25mcg	Tablet	1,855,846 L.L
A07AA02	MEDISTAN	G	Nystatin - 500,000IU	500,000IU	Capsule	417,231 L.L
R01AD09	MOMETASONE BIOGARAN	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	501,253 L.L
A07AA02	MEDISTAN	G	Nystatin - 500,000IU/5ml	500,000IU/5ml	Suspension	415,951 L.L
A07AA02	MEDISTAN	G	Nystatin - 200.000IU	200.000IU	Lozenge	418,511 L.L
J01CR02	MEGAMOX-JPI	G	Amoxicillin (trihydrate) - 500mg, Clavulanic Acid (potassium) - 125mg	625mg	Tablet	245,923 L.L
J07AH	MENFIVE	G	Meningococcal (serogroups A, C, Y, W, X) Polysaccharide conjugate vaccine -		Injectable freeze dried powder + diluent	3,527,587 L.L

صدور قرار وزير رقم 264 تاريخ 3/2/2025 يتعلق بتنظيم عمل المؤسسات الصيدلانية على نظام MediTrack